THERA-PRESTA: what changed
THERA-PRESTA
Largest movements
- Receivables within one year -€1,069
down €1,069 (-6.8%), from €15,669 to €14,600
of which Other amounts receivable: -€1,069
- Cash -€211
down €211 (-55.4%), from €380 to €169
mainly Net result for the year (-€1,134) and Trade debts (-€145)
- Profit (loss) carried forward -€1,134
down €1,134 (-11.7%), from €9,704 to €8,569
- Gross operating margin +€879
up €879 (+35.3%), from -€2,487 to -€1,609
- Other operating charges +€192
up €192 (+384%), from €50 to €242
- Financial income -€170
down €170 (-17.9%), from €947 to €777
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €16,049 | €14,769 | -€1,279 | -8.0% |
| Current assets | 29/58 | €16,049 | €14,769 | -€1,279 | -8.0% |
| Amounts receivable within one year | 40/41 | €15,669 | €14,600 | -€1,069 | -6.8% |
| Trade receivables | 40 | €1,100 | €1,100 | = | 0.0% |
| Other amounts receivable | 41 | €14,569 | €13,500 | -€1,069 | -7.3% |
| Cash at bank and in hand | 54/58 | €380 | €169 | -€211 | -55.4% |
| Total equity and liabilities | 10/49 | €16,049 | €14,769 | -€1,279 | -8.0% |
| Equity | 10/15 | €15,904 | €14,769 | -€1,134 | -7.1% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €9,704 | €8,569 | -€1,134 | -11.7% |
| Amounts payable | 17/49 | €145 | - | -€145 | |
| Amounts payable within one year | 42/48 | €145 | - | -€145 | |
| Trade debts | 44 | €145 | - | -€145 | |
| Suppliers | 440/4 | €145 | - | -€145 | |
| Other operating charges | 640/8 | €50 | €242 | +€192 | +384% |
| Gross operating margin | 9900 | -€2,487 | -€1,609 | +€879 | +35.3% |
| Operating profit (loss) | 9901 | -€2,537 | -€1,851 | +€686 | +27.1% |
| Financial income | 75/76B | €947 | €777 | -€170 | -17.9% |
| Recurring financial income | 75 | €947 | €777 | -€170 | -17.9% |
| Financial charges | 65/66B | €60 | €60 | +€0 | +0.3% |
| Recurring financial charges | 65 | €60 | €60 | +€0 | +0.3% |
| Profit (loss) for the period before taxes | 9903 | -€1,651 | -€1,134 | +€516 | +31.3% |
| Profit (loss) for the period | 9904 | -€1,651 | -€1,134 | +€516 | +31.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,651 | -€1,134 | +€516 | +31.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.